Literature DB >> 25448217

Pituitary atypical adenoma or carcinoma sensitive to temozolomide combined with radiation therapy: a case report of early identification and management.

Chuanhong Zhong1, Senlin Yin, Peizhi Zhou, Shu Jiang.   

Abstract

Pituitary carcinoma is extremely rare and difficult to diagnose early. Here we present a case of highly suspected pituitary malignant adenoma with early chemotherapy and radiation. A 30-year-old woman was admitted for headache and impaired vision, MRI found a sellar mass. Since there was no disturbance in serum hormone levels, she was diagnosed with non-functioning pituitary adenoma before surgery. Transsphenoidal removal of tumor was attempted but only partial resection of tumor was achieved. Pathology findings suggested a diagnosis of adenocarcinoma. PET-CT scan showed the tumor had elevated max standardized uptake value. No other abnormal sites were found, which excluded metastasis to pituitary. After surgery, the patient was treated with temozolomide assisted with radiation and tumor disappeared on MRI. No recurrence was observed on 1-year follow up. In conclusion, early temozolomide with radiation therapy for highly suspected pituitary carcinoma might be beneficial.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25448217     DOI: 10.5137/1019-5149.JTN.9629-13.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  4 in total

1.  Delayed Craniospinal Metastasis of Aggressive Nonfunctioning Pituitary Adenomas as Pituitary Carcinomas.

Authors:  Ashley L B Raghu; Megan C Everson; Ahmed Helal; Satoshi Kiyofuji; Michelle J Clarke; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2021-03-01

2.  Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina.

Authors:  Oscar D Bruno; Lea Juárez-Allen; Silvia B Christiansen; Marcos Manavela; Karina Danilowicz; Carlos Vigovich; Reynaldo M Gómez
Journal:  Int J Endocrinol       Date:  2015-05-27       Impact factor: 3.257

3.  A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma.

Authors:  Ana Misir Krpan; Tina Dusek; Zoran Rakusic; Mirsala Solak; Ivana Kraljevic; Vesna Bisof; David Ozretic; Darko Kastelan
Journal:  Case Rep Endocrinol       Date:  2017-03-05

4.  Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression.

Authors:  Gianina Demarchi; Sofía Perrone; Gaela Esper Romero; Cristian De Bonis; Juan Pablo Casasco; Gustavo Sevlever; Silvia Ines Berner; Carolina Cristina
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.